3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Lung Neoplasms
2
Carcinoma, Renal Cell
2
Adenocarcinoma Of Esophagus
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Ovarian Neoplasms
1
Lung Diseases
1
Kidney Neoplasms
1
Esophageal Neoplasms
1
Erythrocytosis, Familial, 4
1
Cholangiocarcinoma
1
Advanced Non-Small Cell Lung Cancer
1
Interventions
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Platinum
4
Cisplatin
4
1,2-diaminocyclohexaneplatinum II citrate
4
Radiotherapy, Intensity-Modulated
3
Cetuximab
3
Biopsy
3
(225)Ac-DOTA-c(RGDyK)
3
pembrolizumab
2
cemiplimab
2
Radiotherapy
2
Radiation
2
Immunoglobulin G
2
Disulfides
2
Carboplatin
2
ipatasertib
1
durvalumab
1
cabozantinib
1
atezolizumab
1
Transurethral Resection of Bladder
1
Taxes
1
Radiosurgery
1
Paclitaxel
1
Nivolumab
1
Docetaxel
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Laryngeal Neoplasms
×
zimberelimab
×
30 days
×
Clear all
No trials found.